文献速递类风湿关节炎系统性红斑狼疮其他结缔组织病

基础与转化科学年度综述:大数据时代的孔子

The basic and translational science year in review: Confucius in the era of Big Data.
PubMed 文献 · Semin Arthritis Rheum · 2020-03-05

该综述总结了2018-2019年风湿病学基础与转化研究进展,重点介绍大数据方法(如单细胞RNA测序)在类风湿关节炎滑膜和系统性红斑狼疮肾脏组织中的应用,揭示了免疫细胞亚群、成纤维细胞亚群及1型干扰素等致病机制,并提及硬皮病、血管炎及微生物组的相关研究。

要点

  • 单细胞RNA测序可揭示组织病变中血液无法反映的基因表达扰动。
  • 类风湿关节炎滑膜中鉴定出参与滑膜炎的免疫细胞和成纤维细胞亚群。
  • 系统性红斑狼疮转录组研究提示1型干扰素的广泛效应。

核心结论

  • 大数据方法为风湿病精准医疗提供可操作的生物标志物和 novel 治疗靶点。

研究设计与样本

  • 综述2018-2019年基础与转化研究,聚焦Accelerating Medicines Partnership支持的scRNAseq等大数据分析。

主要发现

  • 类风湿关节炎滑膜中鉴定出参与滑膜炎的免疫细胞和成纤维细胞亚群。
  • 系统性红斑狼疮转录组研究提供1型干扰素广泛效应的证据。
  • 进行性硬化症研究显示干细胞治疗相关变化及抗纤维化新靶点。
  • 分子方法定义了血管炎新机制及微生物组在炎症性关节炎和SLE中的潜在作用。

临床怎么用

  • 未来大数据研究将整合炎症中细胞空间关系及基因表达随时间的变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Personalized medicine is an important goal for the treatment of rheumatic disease that seeks to improve outcomes by matching therapy more precisely with the underlying pathogenetic disturbances in the individual patient. Realization of this goal requires actionable biomarkers to identify these disturbances as well as pathways that can be targeted for novel therapy. Among advances in characterizing pathogenesis, Big Data provides an unprecedented picture of pathogenesis, with analysis of tissue lesions revealing disturbances that may not be apparent in blood. Big Data approaches include single cell RNAseq (scRNAseq) which can elucidate patterns of gene expression by individual cells. Galvanized by the Accelerating Medicines Partnership, a public-private initiative of the NIH, investigative teams have analyzed gene expression in cells in the synovium for rheumatoid arthritis and kidney for systemic lupus erythematosus. A review of basic and translational research for 2018-2019 provides the progress in these areas. Thus, the studies on rheumatoid arthritis have identified subpopulations of immune cells and fibroblasts implicated in synovitis. For lupus, transcriptomic studies have provided evidence for widespread effects of type 1 interferon. Studies in progressive sclerosis have demonstrated changes associated with stem cell therapy as well as potential new targets for anti-fibrotic agents. Other studies using molecular approaches have defined new mechanisms for vasculitis as well as the potential role of the microbiome in inflammatory arthritis and systemic lupus erythematosus. Future studies with Big Data will incorporate the spatial relationships of cells in inflammation as well as changes in gene expression over time.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Pisetsky DS. The basic and translational science year in review: Confucius in the era of Big Data. Semin Arthritis Rheum. 2020. PMID: 32238274. doi:10.1016/j.semarthrit.2020.02.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。